Shayne & Jacobs LLC Has $1.12 Million Stock Holdings in Envista Holdings Co. (NYSE:NVST)

Shayne & Jacobs LLC decreased its holdings in Envista Holdings Co. (NYSE:NVST) by 6.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 58,260 shares of the company’s stock after selling 4,340 shares during the quarter. Shayne & Jacobs LLC’s holdings in Envista were worth $1,124,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in NVST. Mirae Asset Global Investments Co. Ltd. acquired a new stake in Envista during the 3rd quarter worth about $31,000. Huntington National Bank lifted its position in shares of Envista by 97.8% during the third quarter. Huntington National Bank now owns 1,919 shares of the company’s stock valued at $38,000 after purchasing an additional 949 shares in the last quarter. Venturi Wealth Management LLC grew its holdings in shares of Envista by 528.4% in the fourth quarter. Venturi Wealth Management LLC now owns 1,948 shares of the company’s stock valued at $38,000 after acquiring an additional 1,638 shares in the last quarter. Blue Trust Inc. increased its position in shares of Envista by 69.7% during the 3rd quarter. Blue Trust Inc. now owns 1,957 shares of the company’s stock valued at $39,000 after purchasing an additional 804 shares during the last quarter. Finally, Allspring Global Investments Holdings LLC increased its holdings in Envista by 50.8% during the third quarter. Allspring Global Investments Holdings LLC now owns 2,161 shares of the company’s stock worth $43,000 after buying an additional 728 shares during the last quarter.

Envista Stock Performance

Shares of NVST stock opened at $20.68 on Wednesday. The business has a 50-day simple moving average of $20.18 and a 200-day simple moving average of $19.62. The company has a quick ratio of 1.76, a current ratio of 2.04 and a debt-to-equity ratio of 0.44. The stock has a market cap of $3.56 billion, a PE ratio of -3.19, a price-to-earnings-growth ratio of 1.27 and a beta of 1.34. Envista Holdings Co. has a 52-week low of $15.15 and a 52-week high of $23.00.

Envista (NYSE:NVST) last issued its quarterly earnings data on Wednesday, February 5th. The company reported $0.24 EPS for the quarter, topping analysts’ consensus estimates of $0.23 by $0.01. Envista had a negative net margin of 44.56% and a positive return on equity of 3.86%. On average, equities analysts expect that Envista Holdings Co. will post 1 EPS for the current year.

Wall Street Analyst Weigh In

A number of research analysts have recently weighed in on the stock. Leerink Partners raised shares of Envista from an “underperform” rating to a “market perform” rating and increased their target price for the company from $16.00 to $23.00 in a research report on Thursday, October 31st. Leerink Partnrs raised Envista from a “strong sell” rating to a “hold” rating in a research report on Thursday, October 31st. Jefferies Financial Group upped their price target on Envista from $20.00 to $22.00 and gave the company a “hold” rating in a research report on Thursday, January 23rd. Needham & Company LLC reissued a “hold” rating on shares of Envista in a report on Tuesday. Finally, Robert W. Baird upped their price objective on shares of Envista from $17.00 to $22.00 and gave the company a “neutral” rating in a report on Thursday, October 31st. Two equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and three have issued a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $20.21.

Envista Company Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.